Author Search Results

Shimon Slavin

Shimon Slavin (born 17 May 1941) is an Israeli professor of medicine. He pioneered immunotherapy mediated by allogeneic donor lymphocytes and innovative methods for stem cell transplantation to cure hematological malignancies and solid tumors. He also used hematopoietic stem cells to induce transplantation tolerance to bone marrow and organ allografts.

More recently, he has been working on the use of multi-potent mesenchymal stem cells (MSCs) in regenerative medicine for the treatment of neurological, systemic, and orthopedic disorders.

He is currently serving as the medical and scientific director of Biotherapy International Center for Innovative Cancer Immunotherapy & Cellular Medicine in Tel Aviv, Israel, and as the medical director at Superinfection, a biotechnology company in Budapest, Hungary. Provided by Wikipedia

1

Successful Treatment of Diabetes in Nod Mice with Advanced Disease by Islet Isografts following Immunoregulation with Linomide (Quinoline-3-Carboxamide)

by Shimon Slavin, Lola Weiss, Xia Wenlang, David J. Gross
Published 1996-11-01

Get full text

Article
2

Heparanase promotes engraftment and prevents graft versus host disease in stem cell transplantation.

by Menachem Bitan, Lola Weiss, Michael Zeira, Eyal Zcharia, Shimon Slavin, Arnon Nagler, Israel Vlodavsky
Published 2010-04-01

Get full text

Article
3

Human mesenchymal stromal cells ameliorate complement induced inflammatory cascade and improve renal functions in a rat model of ischemia-reperfusion induced acute kidney injury.

by Shani Zilberman-Itskovich, Ramzia Abu-Hamad, Rina Zarura, Marina Sova, Yafit Hachmo, Moshe Stark, Sara Neuman, Shimon Slavin, Shai Efrati
Published 2019-01-01

Get full text

Article
4

Telomere shortening sensitizes cancer cells to selected cytotoxic agents: in vitro and in vivo studies and putative mechanisms.

by Orit Uziel, Einat Beery, Vladimir Dronichev, Katty Samocha, Sergei Gryaznov, Lola Weiss, Shimon Slavin, Michal Kushnir, Yardena Nordenberg, Claudette Rabinowitz, Baruch Rinkevich, Tania Zehavi, Meir Lahav
Published 2010-01-01

Get full text

Article
5

Human Peripheral Blood Mononuclear Cells Incubated in Vasculogenic Conditioning Medium Dramatically Improve Ischemia/Reperfusion Acute Kidney Injury in Mice

by Takayasu Ohtake, Shuzo Kobayashi, Shimon Slavin, Yasuhiro Mochida, Kunihiro Ishioka, Hidekazu Moriya, Sumi Hidaka, Ryo Matsuura, Maki Sumida, Daisuke Katagiri, Eisei Noiri, Kayoko Okada, Hiroshi Mizuno, Rica Tanaka
Published 2018-03-01

Get full text

Article
6

MicroRNA-145 is downregulated in glial tumors and regulates glioma cell migration by targeting connective tissue growth factor.

by Hae Kyung Lee, Ariel Bier, Simona Cazacu, Susan Finniss, Cunli Xiang, Hodaya Twito, Laila M Poisson, Tom Mikkelsen, Shimon Slavin, Elad Jacoby, Michal Yalon, Amos Toren, Sandra A Rempel, Chaya Brodie
Published 2013-01-01

Get full text

Article